Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 128Brain Neoplasms 114Prostatic Neoplasms 101Neoplasm Metastasis 83Lung Neoplasms 71Carcinoma, Hepatocellular 71Pancreatic Neoplasms 67Breast Neoplasms 47Melanoma 44Carcinoma, Renal Cell 36Neoplasms 33Colorectal Neoplasms 26Squamous Cell Carcinoma of Head and Neck 25Glioblastoma 24Liver Neoplasms 20Head and Neck Neoplasms 16Small Cell Lung Carcinoma 15Sarcoma 13Glioma 12Kidney Neoplasms 11Urinary Bladder Neoplasms 9Recurrence 9Gliosarcoma 8Ovarian Neoplasms 7Adenocarcinoma of Lung 7Adenocarcinoma 7Prostate Cancer Metastatic 6Cholangiocarcinoma 6Central Nervous System Neoplasms 6Uveal Melanoma 5

Interventions

Vincristine 16Cyclophosphamide 16Filgrastim 13Etoposide 12Doxorubicin 12Radiotherapy 11Carboplatin 10X-Rays 9Dactinomycin 9Specimen Handling 8Phantoms, Imaging 8Magnetic Resonance Spectroscopy 8Granulocyte Colony-Stimulating Factor 8Temozolomide 6Melphalan 6Ifosfamide 6Topotecan 5Peripheral Blood Stem Cell Transplantation 5Nuclear Medicine Department, Hospital 5Irinotecan 5Busulfan 5Biopsy 5sargramostim 4Stem Cell Transplantation 4Thiotepa 3Radiation 3Nivolumab 3Mesna 3Itraconazole 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Wilms Tumor × Radiosurgery × Clear all
NCT02581384 2021-04-30

Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors

Dana-Farber Cancer Institute

Phase 1/2 Terminated
5 enrolled 9 charts
GenitourinarySarcoma

Carcinoma, Renal Cell, Neoplasm Metastasis, Wilms Tumor, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡